BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 8389909)

  • 1. The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function.
    Venkatesh LK; Chinnadurai G
    J Virol; 1993 Jul; 67(7):3868-76. PubMed ID: 8389909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants.
    Venkatesh LK; Yang C; Theodorakis PA; Chinnadurai G
    J Virol; 1993 Jan; 67(1):161-9. PubMed ID: 8380068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bel1 protein of human foamy virus contains one positive and two negative control regions which regulate a distinct activation domain of 30 amino acids.
    Lee CW; Chang J; Lee KJ; Sung YC
    J Virol; 1994 Apr; 68(4):2708-19. PubMed ID: 8139046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct cis-acting regions in U3 regulate trans-activation of the human spumaretrovirus long terminal repeat by the viral bel1 gene product.
    Venkatesh LK; Theodorakis PA; Chinnadurai G
    Nucleic Acids Res; 1991 Jul; 19(13):3661-6. PubMed ID: 1649456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus.
    Lee KJ; Lee AH; Sung YC
    J Virol; 1993 Apr; 67(4):2317-26. PubMed ID: 8383244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel1 protein requires a specific DNA sequence.
    Lee AH; Lee KJ; Kim S; Sung YC
    J Virol; 1992 May; 66(5):3236-40. PubMed ID: 1313928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human foamy virus Bel1 transactivator contains a bipartite nuclear localization determinant which is sensitive to protein context and triple multimerization domains.
    Chang J; Lee KJ; Jang KL; Lee EK; Baek GH; Sung YC
    J Virol; 1995 Feb; 69(2):801-8. PubMed ID: 7815546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residues R(199)H(200) of prototype foamy virus transactivator Bel1 contribute to its binding with LTR and IP promoters but not its nuclear localization.
    Ma Q; Tan J; Cui X; Luo D; Yu M; Liang C; Qiao W
    Virology; 2014 Jan; 449():215-23. PubMed ID: 24418555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional domains of the simian foamy virus type 1 transcriptional transactivator (Taf).
    Mergia A; Renshaw-Gegg LW; Stout MW; Renne R; Herchenröeder O
    J Virol; 1993 Aug; 67(8):4598-604. PubMed ID: 8392601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter.
    Löchelt M; Muranyi W; Flügel RM
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7317-21. PubMed ID: 8394017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the internal promoter of simian foamy viruses.
    Campbell M; Renshaw-Gegg L; Renne R; Luciw PA
    J Virol; 1994 Aug; 68(8):4811-20. PubMed ID: 8035481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gene expression of human foamy virus does not require a post-transcriptional transactivator.
    Lee AH; Lee HY; Sung YC
    Virology; 1994 Oct; 204(1):409-13. PubMed ID: 7522374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1.
    Mergia A; Pratt-Lowe E; Shaw KE; Renshaw-Gegg LW; Luciw PA
    J Virol; 1992 Jan; 66(1):251-7. PubMed ID: 1309244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional organization of the Bel-1 trans activator of human foamy virus.
    He F; Sun JD; Garrett ED; Cullen BR
    J Virol; 1993 Apr; 67(4):1896-904. PubMed ID: 8383217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional trans activators of human and simian foamy viruses contain a small, highly conserved activation domain.
    Garrett ED; He F; Bogerd HP; Cullen BR
    J Virol; 1993 Nov; 67(11):6824-7. PubMed ID: 8411385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter.
    Kang Y; Blair WS; Cullen BR
    J Virol; 1998 Jan; 72(1):504-11. PubMed ID: 9420252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct functional properties of three human paired-box-protein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors.
    Poleev A; Wendler F; Fickenscher H; Zannini MS; Yaginuma K; Abbott C; Plachov D
    Eur J Biochem; 1995 Mar; 228(3):899-911. PubMed ID: 7737192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transacting transcriptional activation of human spumaretrovirus LTR in infected cells.
    Rethwilm A; Mori K; Maurer B; ter Meulen V
    Virology; 1990 Apr; 175(2):568-71. PubMed ID: 2158186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bel1-mediated transactivation of the spumaretroviral internal promoter is repressed by nuclear factor I.
    Kido K; Bannert H; Gronostajski RM; Flügel RM
    J Biol Chem; 2003 Apr; 278(14):11836-42. PubMed ID: 12446690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.